| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $443.6M | +32.9% |
| Cost of Revenue | $187.0M | +36.3% |
| Gross Profit | $256.6M | +30.5% |
| R&D Expense | $118.4M | +23.1% |
| SG&A Expense | $100.9M | +20.6% |
| Operating Income | -$53.6M | -20.2% |
| Pre-tax Income | -$59.0M | -45.5% |
| Income Tax | -$11.3M | -3772.1% |
| Net Income | -$47.7M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $63.5M | -32.7% |
| Accounts Receivable | $51.5M | +32.9% |
| Current Assets | $187.2M | +3.2% |
| Total Assets | $847.2M | +93.8% |
| Current Liabilities | $89.5M | +96.5% |
| Total Liabilities | $485.2M | +504.6% |
| Stockholders' Equity | $362.0M | +1.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $42.9M | +130.7% |
| Capital Expenditures | $1.5M | +29.0% |
| Investing Cash Flow | -$397.6M | -1825.6% |
| Financing Cash Flow | $323.8M | +2645.3% |
| Free Cash Flow | $41.4M | +137.7% |
| -16.7% |
| EPS (Basic) | -$0.46 | -12.2% |
| EPS (Diluted) | -$0.46 | -12.2% |